Physician profile
Avi Malkis
NPI 1063785905
$1,033.11
in general payments reported to CMS, 2019-2025
12 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $183 · 2021: $25.63 · 2022: $371 · 2023: $73.22 · 2024: $78.71 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300 · Education: $14.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $300.49 |
| Education | $14.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $420.36 | 2019-2025 | Invisalign, Itero Element 5d Plus |
| Pulpdent Corporation | $136.55 | 2022 | |
| Dentsply Sirona INC | $118.97 | 2020-2024 | Suresmile |
| Zimmer Biomet Holdings, INC. | $112.13 | 2019-2020 | |
| Philips North America LLC | $60.73 | 2021-2025 | (E55) Oral Health Care Und, Oral Health Care Undivided |
| Straumann USA LLC | $53.70 | 2020 | |
| Voco America INC. | $32.70 | 2025 | Admira Fusion X-Tra |
| Kulzer, LLC | $29.94 | 2022-2023 | |
| Zimvie INC. | $21.26 | 2023 | |
| Orapharma, A Division of Bausch Health US, LLC | $17.78 | 2025 | Arestin, Ossix Plus |
| Coltene Whaledent INC. | $14.79 | 2022 | |
| Septodont INC. | $14.20 | 2025 | Biodentine |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avi Malkis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.